ArticleCell death and differentiation2023

Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification.

Ozge Saatci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.